Latest Articles

Publication Date
Why endometriosis could be unfairly costing women £130 a month - MSN

Why endometriosis could be unfairly costing women £130 a month MSN

Published: Jan. 3, 2026, 4:05 a.m.
Fucoxanthin regulates macrophage pyroptosis through the PI3K/AKT/mTOR signalling pathway.

Pyroptosis has been reported to occur in several diseases, such as atherosclerosis, nonalcoholic steatohepatitis, and endometriosis. Although fucoxanthin has several biological properties (particularly anti-inflammatory properties), the mechanism through which fucoxanthin …

Published: Jan. 3, 2026, midnight
Investigating the role of artificial intelligence in the diagnosis and prediction of endometriosis using ultrasound images: a systematic review.

Published: Jan. 3, 2026, midnight
Influence of Tubal Patency on Endometriosis Recurrence: a Retrospective Matched Case-control Study.

To study if bilateral non-patency of fallopian tubes is correlated with a lower recurrence rate of endometriosis.

Published: Jan. 3, 2026, midnight
AI-Enhanced MRI Radiomics for Discriminating Active and Fibrotic Lesions to Support Therapeutic Decision-Making in Deep Endometriosis.

This study investigates whether quantitative analysis of preoperative Magnetic Resonance Imaging (MRI) scans can differentiate deep infiltrating endometriosis (DIE) lesion types (active or fibrotic) and associate them with reported pain …

Published: Jan. 3, 2026, midnight
Applications of Exosomes in Female Medicine: A Systematic Review of Molecular Biology, Diagnostic and Therapeutic Perspectives.

Exosomes are nanoscale extracellular vesicles that mediate intercellular communication by transporting microRNAs, proteins, and lipids. Generated through Endosomal Sorting Complex Required for Transport (ESCRT)-dependent mechanisms or ESCRT-independent pathways, exosomes are …

Published: Jan. 3, 2026, midnight
Endometrial Cancer: Sequencing Lenvatinib–Pembrolizumab - Alignment with Trials, Post-Adjuvant Potential, and Dose Flexibility - OncLive

Endometrial Cancer: Sequencing Lenvatinib–Pembrolizumab - Alignment with Trials, Post-Adjuvant Potential, and Dose Flexibility OncLive

Published: Jan. 2, 2026, 1:12 p.m.
Endometrial Cancer: Framing Prognosis, Weaving Clinical Trials and Real-World Data into Patient Conversations - OncLive

Endometrial Cancer: Framing Prognosis, Weaving Clinical Trials and Real-World Data into Patient Conversations OncLive

Published: Jan. 2, 2026, 1:10 p.m.
FOGSI Consensus Redefines Endometriosis Care with Oral GnRH Antagonist, Elagolix - Medical Dialogues

FOGSI Consensus Redefines Endometriosis Care with Oral GnRH Antagonist, Elagolix Medical Dialogues

Published: Jan. 2, 2026, 6:13 a.m.
Clarifying the natural course of endometriosis remains essential.

Published: Jan. 2, 2026, midnight
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!